BACKGROUND: Previously, we found an increased prevalence of thyroid autoantibodies in patients with bipolar disorder. In the present study, we investigated other signs of immune activation in bipolar patients, in particular an activation of the T cell system. METHODS: Fluorescence activated cell scanning (FACS) analysis was performed on lymphocytes of 64 outpatients with DSM-IV bipolar disorder using the T cell marker CD3 in combination with the activation markers MHC-class II, CD25, CD69 or CD71. In 34 patients, these assays were repeated after an interval of 2 years. In addition, T cell activation was determined by measuring serum soluble IL-2 receptor (sIL-2R) in 172 bipolar outpatients. Outcomes were compared with a healthy control group. RESULTS: Significantly higher numbers of circulating activated T cells and raised sIL-2R levels were found in euthymic, manic, and depressed bipolar patients when compared with healthy controls. In general, these abnormalities were stable over time. Manic patients showed significantly higher levels of sIL-2R in comparison with depressed patients. CONCLUSION: The T cell system was found to be activated in both symptomatic and euthymic patients with bipolar disorder. The pathophysiological significance of these findings remains to be explored.
BACKGROUND: Previously, we found an increased prevalence of thyroid autoantibodies in patients with bipolar disorder. In the present study, we investigated other signs of immune activation in bipolarpatients, in particular an activation of the T cell system. METHODS: Fluorescence activated cell scanning (FACS) analysis was performed on lymphocytes of 64 outpatients with DSM-IV bipolar disorder using the T cell marker CD3 in combination with the activation markers MHC-class II, CD25, CD69 or CD71. In 34 patients, these assays were repeated after an interval of 2 years. In addition, T cell activation was determined by measuring serum soluble IL-2 receptor (sIL-2R) in 172 bipolar outpatients. Outcomes were compared with a healthy control group. RESULTS: Significantly higher numbers of circulating activated T cells and raised sIL-2R levels were found in euthymic, manic, and depressed bipolarpatients when compared with healthy controls. In general, these abnormalities were stable over time. Manicpatients showed significantly higher levels of sIL-2R in comparison with depressedpatients. CONCLUSION: The T cell system was found to be activated in both symptomatic and euthymic patients with bipolar disorder. The pathophysiological significance of these findings remains to be explored.
Authors: Gabriela D Colpo; Marion Leboyer; Robert Dantzer; Mahdukar H Trivedi; Antonio L Teixeira Journal: Expert Rev Neurother Date: 2017-11-27 Impact factor: 4.618
Authors: Hasan Mayda; Ahmet Ahsen; Erman Bağcioğlu; Ahmet Öztürk; Bülent Bahçeci; Etem Soyuçok; Erol Başpinar; Memnune Sena Ulu Journal: Noro Psikiyatr Ars Date: 2016-12-01 Impact factor: 1.339
Authors: Joanna K Soczynska; Sidney H Kennedy; Hanna O Woldeyohannes; Samantha S Liauw; Mohammad Alsuwaidan; Christina Y Yim; Roger S McIntyre Journal: Neuromolecular Med Date: 2010-12-17 Impact factor: 3.843
Authors: Michael Maes; Joao Victor Nani; Cristiano Noto; Lucas Rizzo; Mirian A F Hayashi; Elisa Brietzke Journal: Mol Neurobiol Date: 2020-09-11 Impact factor: 5.590
Authors: Benjamin I Goldstein; Francis Lotrich; David A Axelson; Mary Kay Gill; Heather Hower; Tina R Goldstein; Jieyu Fan; Shirley Yen; Rasim Diler; Daniel Dickstein; Michael A Strober; Satish Iyengar; Neal D Ryan; Martin B Keller; Boris Birmaher Journal: J Clin Psychiatry Date: 2015-11 Impact factor: 4.384
Authors: Lucas B Rizzo; Walter Swardfager; Pawan Kumar Maurya; Maiara Zeni Graiff; Mariana Pedrini; Elson Asevedo; Ana Cláudia Cassinelli; Moisés E Bauer; Quirino Cordeiro; Jan Scott; Elisa Brietzke; Hugo Cogo-Moreira Journal: Int J Methods Psychiatr Res Date: 2018-04-25 Impact factor: 4.035